The metabolic syndrome: Useful concept or clinical tool? Report of a WHO expert consultation

Diabetologia

Volumn 53, Issue 4, 2010, Pages 600-605

  Simmons, R K ^a   Alberti, K G M M ^b   Gale, E A M ^c   Colagiuri, S ^d   Tuomilehto, J ^e,f   Qiao, Q ^e   Ramachandran, A ^g   Tajima, N ^h   Brajkovich Mirchov, I ⁱ   Ben Nakhi, A ^j   Reaven, G ^k   Hama Sambo, B ^l   Mendis, S ^l   Roglic, G ^l  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF HELSINKI   (Finland)

^f SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^g India Diabetes Research Foundation   (India)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^j Dasman Center for Research and Treatment of Diabetes   (Kuwait)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADIPOCYTE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC STRESS; CONSULTATION; GENETIC HETEROGENEITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; INSULIN RESISTANCE; LIVER DISEASE; METABOLIC SYNDROME X; NEOPLASM; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SLEEP APNEA SYNDROME; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; METABOLIC SYNDROME X; OBESITY; PATIENT EDUCATION AS TOPIC; PUBLIC HEALTH; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 77949273315     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1620-4     Document Type: Review

References (35)

1. World Health Organization (2008) 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. WHO, Geneva
2. United Nations (2008) The Millennium Development Goals report 2008. United Nations, New York
3. GM Reaven 1988 Banting Lecture 1988. Role of insulin resistance in human disease Diabetes 37 1595 1607 10.2337/diabetes.37.12.1595 1:STN:280: DyaL1M%2Flt12msQ%3D%3D 3056758
4. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva
5. SM Grundy HB Brewer Jr JI Cleeman SC Smith Jr C Lenfant 2004 Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 433 438 10.1161/01.CIR.0000111245.75752.C6 14744958 (Pubitemid 38133916)
6. B Balkau MA Charles 1999 Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 16 442 443 10.1046/j.1464-5491.1999.00059.x 1:STN:280:DyaK1M3ntFOktg%3D%3D 10342346
7. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet 366 1059 1062 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
8. KG Alberti RH Eckel SM Grundy, et al. 2009 Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 1:CAS:528: DC%2BD1MXht1OrtrrK 19805654
9. R Kahn J Buse E Ferrannini M Stern 2005 The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 48 1684 1699 10.1007/s00125-005-1876-2 1:STN:280:DC%2BD2MvptF2hsg%3D%3D 16079964 (Pubitemid 41317821)
10. RH Eckel SM Grundy PZ Zimmet 2005 The metabolic syndrome Lancet 365 1415 1428 10.1016/S0140-6736(05)66378-7 1:CAS:528:DC%2BD2MXjsVegtbg%3D 15836891 (Pubitemid 40523737)
11. DB Carr KM Utzschneider RL Hull, et al. 2004 Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087 2094 10.2337/diabetes.53.8.2087 1:CAS:528:DC%2BD2cXmtFGqtrk%3D 15277390 (Pubitemid 38970759)
12. ES Ford 2005 Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 1769 1778 10.2337/diacare.28.7.1769 15983333 (Pubitemid 40923091)
13. DS Fernandez-Twinn SE Ozanne 2006 Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome Physiol Behav 88 234 243 10.1016/j.physbeh.2006.05.039 1:CAS:528:DC%2BD28Xmt1Oqtrs%3D 16782139 (Pubitemid 43913894)
14. M Sjogren V Lyssenko A Jonsson, et al. 2008 The search for putative unifying genetic factors for components of the metabolic syndrome Diabetologia 51 2242 2251 10.1007/s00125-008-1151-4 1:STN:280:DC%2BD1cjhvF2isA%3D%3D 18853134
15. A Kotronen H Yki-Jarvinen 2008 Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 27 38 10.1161/ATVBAHA.107. 147538 1:CAS:528:DC%2BD2sXhsVeiu7nI 17690317
16. AN Vgontzas EO Bixler GP Chrousos 2005 Sleep apnea is a manifestation of the metabolic syndrome Sleep Med Rev 9 211 224 10.1016/j.smrv.2005.01.006 15893251 (Pubitemid 40694188)
17. A Russo M Autelitano L Bisanti 2008 Metabolic syndrome and cancer risk Eur J Cancer 44 293 297 10.1016/j.ejca.2007.11.005 18055193
18. Wild SH, Byrne CD (2005) The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Wild SH, Byrne CD (eds) The metabolic syndrome. Wiley, Chichester, pp 1-43
19. R Weiss J Dziura TS Burgert, et al. 2004 Obesity and the metabolic syndrome in children and adolescents N Engl J Med 350 2362 2374 10.1056/NEJMoa031049 1:CAS:528:DC%2BD2cXks1Gjt70%3D 15175438 (Pubitemid 38702847)
20. A Esmaillzadeh P Mirmiran L Azadbakht A Etemadi F Azizi 2006 High prevalence of the metabolic syndrome in Iranian adolescents Obesity 14 377 382 10.1038/oby.2006.50 16648607 (Pubitemid 46219755)
21. GM Reaven 2006 The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83 1237 1247 1:CAS:528:DC%2BD28XlvFCmtL4%3D 16762930
22. DM Eddy L Schlessinger K Heikes 2008 The metabolic syndrome and cardiovascular risk: implications for clinical practice Int J Obes 32 Suppl 2 S5 10 10.1038/ijo.2008.28 1:CAS:528:DC%2BD1cXlslSjtbo%3D (Pubitemid 351671295)
23. CM Lee RR Huxley M Woodward, et al. 2008 The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region Diabetes Res Clin Pract 8 377 380 10.1016/j.diabres.2008.05. 011
24. N Sattar A McConnachie AG Shaper, et al. 2008 Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies Lancet 371 1927 1935 10.1016/S0140-6736(08)60602-9 18501419
25. P Kohli P Greenland 2006 Role of the metabolic syndrome in risk assessment for coronary heart disease JAMA 295 819 821 10.1001/jama.295.7.819 1:CAS:528:DC%2BD28XhsFOrsb4%3D 16482657 (Pubitemid 43244309)
26. AJ Cameron DJ Magliano PZ Zimmet, et al. 2008 The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study J Intern Med 264 177 186 10.1111/j.1365-2796.2008.01935.x 1:STN:280:DC%2BD1crhvVSksg%3D%3D 18298479 (Pubitemid 351962573)
27. G Mancia M Bombelli G Corrao, et al. 2007 Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis Hypertension 49 40 47 10.1161/01.HYP.0000251933.22091.24 1:CAS:528:DC%2BD28XhtlSrs7nN 17130308 (Pubitemid 46360339)
28. J Stevens JE McClain KP Truesdale 2008 Selection of measures in epidemiologic studies of the consequences of obesity Int J Obes 32 Suppl 3 S60 S66 10.1038/ijo.2008.88
29. D Canoy 2008 Distribution of body fat and risk of coronary heart disease in men and women Curr Opin Cardiol 23 591 598 10.1097/HCO.0b013e328313133a 18830075
30. S Mendis LH Lindholm G Mancia, et al. 2007 World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries J Hypertens 25 1578 1582 10.1097/HJH.0b013e3282861fd3 1:CAS:528:DC%2BD2sXnsVCrsrY%3D 17620952 (Pubitemid 47056562)
31. T Kohro Y Furui N Mitsutake, et al. 2008 The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome Int Heart J 49 193 203 10.1536/ihj.49.193 18475019 (Pubitemid 351902983)
32. A Ramachandran C Snehalatha S Mary B Mukesh AD Bhaskar V Vijay 2006 The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 49 289 297 10.1007/s00125-005-0097-z 1:CAS:528:DC%2BD28XhtFWnurc%3D 16391903 (Pubitemid 43185397)
33. J Tuomilehto J Lindstrom JG Eriksson, et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 1343 1350 10.1056/NEJM200105033441801 1:STN:280:DC%2BD3M3kvFejsA%3D%3D 11333990 (Pubitemid 32378388)
34. WC Knowler E Barrett-Connor SE Fowler, et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 393 403 10.1056/NEJMoa012512 1:CAS:528:DC%2BD38XhtVWqurc%3D 11832527 (Pubitemid 34437694)
35. H Eyre R Kahn RM Robertson, et al. 2004 Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association Circulation 109 3244 3255 10.1161/01.CIR.0000133321.00456.00 15198946